Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Faron Pharmaceuticals Oy (OP:FPHAF)

N/A UNCHANGED
Last Price Updated: 9:30 AM EST, Feb 11, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Faron Pharmaceuticals Oy

Faron Pharmaceuticals presents "very positive" Phase 1 data at ASH Conference
--News Direct-- 
Via News Direct
Faron Pharmaceuticals presents "very positive" Phase 1 data at ASH Conference
Faron Pharmaceuticals Limited (AIM:FARN, OTC:FPHAF) chief executive Dr Markku Jalkanen speaks to Thomas Warner from Proactive London after the clinical stage biopharmaceutical company announced "very... 
Via TheNewswire.com
Faron Pharmaceuticals initiates second phase of BEXMAB study
--News Direct-- 
Via News Direct
Faron Pharmaceuticals initiates second phase of BEXMAB study
Faron Pharmaceuticals Limited (AIM:FARN, OTC:FPHAF) chief executive Dr Markku Jalkanen speaks to Thomas Warner from Proactive London after the clinical-stage biopharmaceutical company announced it has... 
Via TheNewswire.com
Faron Pharmaceuticals CEO delighted with latest BEXMAB study findings
--News Direct-- 
Via News Direct
Faron Pharmaceuticals moving "into next phase" with new CFO
Faron Pharmaceuticals Limited (AIM:FARN, OTC:FPHAF) chief financial officer James O'Brien speaks to Proactive on his second day in the new role. 
Via TheNewswire.com
Faron Pharmaceuticals CEO delighted with latest BEXMAB study findings
Faron Pharmaceuticals Limited (AIM:FARN, OTC:FPHAF) chief executive Dr Markku Jalkanen speaks to Thomas Warner from Proactive London after the clinical stage biopharmaceutical company revealed fresh... 
Via TheNewswire.com
Faron Pharmaceuticals kicks off second half with FDA announcement
--News Direct-- 
Via News Direct
Exposures Product Safety
Faron Pharmaceuticals kicks off second half with FDA announcement
Faron Pharmaceuticals Limited (AIM:FARN, OTC:FPHAF) CEO Markku Jalkanen and CFO James O'Brien speak to Thomas Warner from Proactive after the clinical stage biopharmaceutical company revealed its been... 
Via TheNewswire.com
Exposures Product Safety
Faron Pharmaceuticals hoping for first filing of BLA in H1 2025
--News Direct-- 
Via News Direct
Faron Pharmaceuticals hoping for first filing of BLA in H1 2025
Faron Pharmaceuticals Limited (AIM:FARN, OTC:FPHAF) Chief Medical Officer Marie-Louise Fjällskog speaks to Thomas Warner from Proactive after releasing an update on progress with the clinical stage... 
Via TheNewswire.com
Faron Pharmaceuticals moving "into next phase" with new CFO
Faron Pharmaceuticals moving "into next phase" with new CFO 
Via News Direct
Faron Pharmaceuticals CMO "looking forward to a year filled with good data for the patients"
Faron Pharmaceuticals CMO "looking forward to a year filled with good data for the patients" 
Via News Direct
Faron Pharmaceuticals CMO "looking forward to a year filled with good data for the patients"
Faron Pharmaceuticals Limited (AIM:FARN, OTC:FPHAF) chief medical officer Marie-Louise Fjällskog updates Proactive's Thomas Warner the clinical-stage biopharmaceutical company's wholly-owned precision... 
Via TheNewswire.com
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.